<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04638088</url>
  </required_header>
  <id_info>
    <org_study_id>GCS-ELSAN-0620</org_study_id>
    <nct_id>NCT04638088</nct_id>
  </id_info>
  <brief_title>Comparison of Radical Prostatectomy Performed by Robot-assisted Laparoscopy or Conventional Laparoscopy or by Laparotomy</brief_title>
  <acronym>EMUPRO</acronym>
  <official_title>Comparison of Radical Prostatectomy for the Treatment of Prostate Cancer, Performed by Robot-assisted or Standard Laparoscopy or by Laparotomy : a Multicentric Prospective Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Elsan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Elsan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Minimally invasive surgery has developed widely since the 1980s and has revolutionized the&#xD;
      practices of surgeons. In urology, the development of laparoscopy and then robot-assisted&#xD;
      surgery has considerably improved the management of pathologies. In France, as in all the&#xD;
      countries concerned, the spread of robotic surgery has taken place without prior studies&#xD;
      validating this new technology, nor organizational rules in terms of quality and access to&#xD;
      care. The report of the Haute Autorité de Santé dated November 2016 underlines the weakness&#xD;
      of the methodological quality of studies and meta-analyzes evaluating robot-assisted total&#xD;
      prostatectomy compared to other surgical techniques by laparotomy or conventional&#xD;
      laparoscopy. It therefore appears important to evaluate in a large study the interest of this&#xD;
      technique in order to help the authorities to decide on the real benefit of this technology&#xD;
      and to provide reliable answers to the patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Minimally invasive surgery has developed widely since the 1980s and has revolutionized the&#xD;
      practices of surgeons. In urology, the development of laparoscopy and then robot-assisted&#xD;
      surgery has considerably improved the management of pathologies. In France, as in all the&#xD;
      countries concerned, the spread of robotic surgery has taken place without prior studies&#xD;
      validating this new technology, nor organizational rules in terms of quality and access to&#xD;
      care. The report of the Haute Autorité de Santé dated November 2016 underlines the weakness&#xD;
      of the methodological quality of studies and meta-analyzes evaluating robot-assisted total&#xD;
      prostatectomy compared to other surgical techniques by laparotomy or conventional&#xD;
      laparoscopy. It therefore appears important to evaluate in a large study the interest of this&#xD;
      technique in order to help the authorities to decide on the real benefit of this technology&#xD;
      and to provide reliable answers to the patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2021</start_date>
  <completion_date type="Anticipated">January 10, 2027</completion_date>
  <primary_completion_date type="Anticipated">February 25, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Impact of the prostatectomy procedure (robot assisted laparoscopy, conventional laparoscopy and surgical laparotomy) on the urinary function assessed by the EPIC 50 score</measure>
    <time_frame>45 Days after the surgery</time_frame>
    <description>Comparison of the prostatectomy performed by robot assisted laparoscopy or conventional laparoscopy and by surgical laparotomy on the urinary function assessed by the EPIC 50 score (Expanded Prostate Cancer Index Composite)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>impact of the robot assisted laparoscopy compared to conventional laparoscopy and by surgical laparotomy in radical prostatectomy on the erectile function assessed by the EPIC 50 score</measure>
    <time_frame>45 Days after the surgery</time_frame>
    <description>impact of the robot assisted laparoscopy compared to conventional laparoscopy and by surgical laparotomy on the erectile function assessed by he EPIC 50 score (Expanded Prostate Cancer Index Composite)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>impact of the robot assisted laparoscopy in prostatectomy on the urinary function assessed by EPIC 50 SCORE</measure>
    <time_frame>up to 5 years after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>impact of the robot assisted laparoscopy in prostatectomy on the erectile function assessed by the International Index of Erectile Function (IIEF-5) score</measure>
    <time_frame>upt to 5 years after the surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of the cost effectiveness of the robot assisted procedure in prostatectomy assessed by EQ5d-5L score</measure>
    <time_frame>12 months</time_frame>
    <description>Assessment of the cost effectiveness of the robot assisted procedure in prostatectomy assessed by EQ5d-5L score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurence of prostatectomy sequelae (urinary incontinence or erectile dysfunction )</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurence of prostatectomy sequelae (urinary incontinence or erectil dysfunction )</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prostate Specific Antigen (PSA) level</measure>
    <time_frame>up to 5 years</time_frame>
    <description>measures of the level of PSA in a man's blood</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>robot-assisted laparoscopy</arm_group_label>
    <description>radical prostatectomy performed by robot-assisted laparoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conventional laparoscopy</arm_group_label>
    <description>radical prostatectomy performed by conventional laparoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>laparotomy</arm_group_label>
    <description>radical prostatectomy performed by laparotomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>assessment of urinary function and erectil function before and after prostatectomy</intervention_name>
    <description>assessment of urinary function and erectil function before and after prostatectomy performed by robot assisted or conventional laparoscopy or laparotomy will complete</description>
    <arm_group_label>conventional laparoscopy</arm_group_label>
    <arm_group_label>laparotomy</arm_group_label>
    <arm_group_label>robot-assisted laparoscopy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patient hospitalized for a planned radical prostactectomy .&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient hospitalized for a planned radical prostatectomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Consent refusal from the patient&#xD;
&#xD;
          -  Patients protected by law (Art.L 1121-5, 1121-6, 1121-8 du Code de la santé publique)&#xD;
&#xD;
          -  Absence of a French Health Care Insurance coverage&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shahnaz KLOUCHE, MD</last_name>
    <role>Study Director</role>
    <affiliation>Elsan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shahnaz KLOUCHE, MD</last_name>
    <phone>00331 58 56 41 71</phone>
    <email>klouche@elsan.care</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital Privé La Châtaigneraie</name>
      <address>
        <city>Beaumont</city>
        <zip>63110</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bertrand DE LONG, MD</last_name>
      <phone>00334 73 40 80 40</phone>
      <email>bertrandlong@hotmail.fr</email>
    </contact>
    <investigator>
      <last_name>BERTRAND DE LONG</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique de Saint AUGUSTIN</name>
      <address>
        <city>Bordeaux</city>
        <zip>33074</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Thierry PIECHAUD, MD</last_name>
      <phone>0033 826 30 31 30</phone>
      <email>pthpiechaud@hotmail.fr</email>
    </contact>
    <investigator>
      <last_name>Pierre Thierry PIECHAUD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Polyclinique Médipôle Saint-Roch</name>
      <address>
        <city>Cabestany</city>
        <zip>6633</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicolas LETANG, MD</last_name>
      <phone>00334 28 63 10 10</phone>
      <email>nicolasletang@yahoo.fr</email>
    </contact>
    <investigator>
      <last_name>Nicolas LETANG, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pôle Santé Sud</name>
      <address>
        <city>Le Mans</city>
        <zip>72000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olivier BELAS, MD</last_name>
      <phone>0033 2 43 78 38 38</phone>
      <email>obelas@albarran.fr</email>
    </contact>
    <investigator>
      <last_name>Olivier BELAS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Polyclinique de Gentilly</name>
      <address>
        <city>Nancy</city>
        <zip>54100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicolas HUBERT, MD</last_name>
      <phone>00333 83 93 50 00</phone>
      <email>n.hubert@urolor.fr</email>
    </contact>
    <investigator>
      <last_name>Nicolas HUBERT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Saint-Augustin</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Quentin Come LE CLERC, MD</last_name>
      <phone>003302 40 12 30 00</phone>
      <email>quentin.come@hotmail.fr</email>
    </contact>
    <investigator>
      <last_name>Quentin Come LE CLERC, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Guillaume De Varye</name>
      <address>
        <city>Saint-Doulchard</city>
        <zip>18230</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Florent MAILLARD, MD</last_name>
      <phone>00332 48 68 84 84</phone>
      <email>fmaillard59@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Florent MAILLARD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre clinical</name>
      <address>
        <city>Soyaux</city>
        <zip>16800</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Serge Gabriele, MD</last_name>
      <phone>00335 45 97 88 00</phone>
      <email>sgabriele@centre-clinical.fr</email>
    </contact>
    <investigator>
      <last_name>Serge Gabriele, md</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique de l'Estrée</name>
      <address>
        <city>Stains</city>
        <zip>93240</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Emmanuel BLANC, MD</last_name>
      <phone>00331 49 71 71 71</phone>
      <email>emmanuel.blanc12@free.fr</email>
    </contact>
    <investigator>
      <last_name>Emmanuel BLANC</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital privé Océane</name>
      <address>
        <city>Vannes</city>
        <zip>56000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Herve MONSAINT, MD</last_name>
      <phone>00332 97 62 57 30</phone>
      <email>hervemonsaint@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Hervé MONSAINT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>November 16, 2020</study_first_submitted>
  <study_first_submitted_qc>November 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2020</study_first_posted>
  <last_update_submitted>March 10, 2021</last_update_submitted>
  <last_update_submitted_qc>March 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>robot-assisted laparoscopy</keyword>
  <keyword>laparotomy</keyword>
  <keyword>conventional laparoscopy</keyword>
  <keyword>prostatectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

